Hyperglycemia
This medicine may increase blood sugar.
Medicine information FOSTER 200mcg / 6mcg pressurized inhalation solution
- Product code:
- W62575003
- Quantity:
- 1
- Indicated for:
- asthma; chronic obstructive pulmonary disease
- Route of administration:
- inhalation
- Substance:
- beclomethasone + formoterol (bronchodilator+beta-2 adrenergic agonist)
- ATC
- R03AK08 — Respiratory system | Adrenergics, inhalants | Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics
Beclometasone + formoterol is a combination of a corticosteroid and a long-acting beta-agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD). Beclometasone reduces airway inflammation, while formoterol relaxes the smooth muscles of the bronchi, improving airflow.
This combination is administered as an inhaler, usually twice daily, as maintenance therapy to prevent symptoms and exacerbations. It is indicated for patients requiring both inflammation control and bronchodilation.
Common side effects include throat irritation, hoarseness, tremors, and palpitations. In rare cases, severe adverse reactions such as paradoxical bronchospasm or hypokalemia may occur. It is important for patients to follow the prescribed dosage and use the inhaler correctly to maximize treatment benefits.
Beclometasone + formoterol is an effective therapeutic option for managing chronic respiratory diseases, contributing to improved quality of life for patients.
This combination is administered as an inhaler, usually twice daily, as maintenance therapy to prevent symptoms and exacerbations. It is indicated for patients requiring both inflammation control and bronchodilation.
Common side effects include throat irritation, hoarseness, tremors, and palpitations. In rare cases, severe adverse reactions such as paradoxical bronchospasm or hypokalemia may occur. It is important for patients to follow the prescribed dosage and use the inhaler correctly to maximize treatment benefits.
Beclometasone + formoterol is an effective therapeutic option for managing chronic respiratory diseases, contributing to improved quality of life for patients.
General data about FOSTER 200mcg / 6mcg
- Substance:
- beclomethasone + formoterol
- Date of latest medicines list:
- 01-10-2026
- Product code:
- W62575003
- Strength:
- 200mcg / 6mcg
- Pharmaceutical form:
- pressurized inhalation solution
- Quantity:
- 1
- Product type:
- Original
- Price:
- 207.03 RON
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for beclomethasone + formoterol
Strengths available for beclomethasone + formoterol
- 100mcg/6mcg/dose
- 200mcg/12mcg
- 200mcg/6mcg
- 200mcg/6mcg/dose
Combinations with other substances
Official documents
Professional information (SmPC) - Romanian
Patient leaflet - Romanian
Packaging and labelling information - Romanian
The correspondence between the document and the displayed text is unconfirmed.
- Source institution
- ANMDMR
- Document language
- Romanian
Warnings:
Breastfeeding warning
Use during breastfeeding only on medical advice.
Pregnancy warning
Use during pregnancy only on medical advice.
Cardiac risk / QT prolongation / arrhythmias
This medicine may increase the risk of heart rhythm disturbances.
Reimbursement lists for FOSTER 200mcg / 6mcg Chiesi
B - Sublist B with 50% discount from the reference price
- Price
- 207.03 RON
- Copayment
- 96.41 RON
- Patient payment
- 110.63 RON